These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1958084)

  • 41. [Treatment of osteoporosis. Not only measurements count].
    MMW Fortschr Med; 2002 Sep; 144(35-36):56. PubMed ID: 12380363
    [No Abstract]   [Full Text] [Related]  

  • 42. Risedronate: a new bisphosphonate for the treatment of osteoporosis.
    Kessenich CR
    Nurse Pract; 2000 Mar; 25(3):106-8. PubMed ID: 10750124
    [No Abstract]   [Full Text] [Related]  

  • 43. 'Stress fracture' in osteoporosis treated with sodium fluoride.
    Gips S; Cohen L; Hardoff R
    Clin Nucl Med; 1991 Mar; 16(3):183-4. PubMed ID: 2032435
    [No Abstract]   [Full Text] [Related]  

  • 44. Etidronate for vertebral osteoporosis after the menopause.
    Drug Ther Bull; 1992 Jun; 30(12):45-6. PubMed ID: 1623814
    [No Abstract]   [Full Text] [Related]  

  • 45. Risedronate for the prevention of fractures in postmenopausal osteoporosis.
    Sickels JM; Nip CS
    Ann Pharmacother; 2002 Apr; 36(4):664-70. PubMed ID: 11918518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.
    Reeve J; Davies UM; Hesp R; McNally E; Katz D
    BMJ; 1990 Aug; 301(6747):314-8. PubMed ID: 2393738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risedronate increases bone mineral density and reduces the vertebral fracture incidence in postmenopausal women.
    Reginster JY
    Clin Exp Rheumatol; 2001; 19(2):121-2. PubMed ID: 11326471
    [No Abstract]   [Full Text] [Related]  

  • 48. [Osteoporosis: its diagnosis, its consequences].
    Hardouin P
    Rev Stomatol Chir Maxillofac; 1997 Nov; 98 Suppl 1():93-5. PubMed ID: 9471709
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bisphosphonates in the treatment of osteoporosis. Principles and efficacy.
    Papapoulos SE
    Ann Med Interne (Paris); 2000 Oct; 151(6):504-10. PubMed ID: 11104931
    [No Abstract]   [Full Text] [Related]  

  • 50. Estrogen and the prevention and treatment of osteoporosis.
    Battistini M
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):44S-49S. PubMed ID: 9273937
    [No Abstract]   [Full Text] [Related]  

  • 51. A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures.
    Gutteridge DH; Stewart GO; Prince RL; Price RI; Retallack RW; Dhaliwal SS; Stuckey BG; Drury P; Jones CE; Faulkner DL; Kent GN; Bhagat CI; Nicholson GC; Jamrozik K
    Osteoporos Int; 2002; 13(2):158-70. PubMed ID: 11908491
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sodium fluoride: too late and too toxic for the elderly osteoporotic patient? Additional comments.
    Seymour DG; Day JJ; Pathy MS
    Age Ageing; 1990 Nov; 19(6):425-6. PubMed ID: 2285014
    [No Abstract]   [Full Text] [Related]  

  • 53. Exploiting and bypassing the bone remodeling cycle to optimize the treatment of osteoporosis.
    Dempster DW
    J Bone Miner Res; 1997 Aug; 12(8):1152-4. PubMed ID: 9258744
    [No Abstract]   [Full Text] [Related]  

  • 54. [Diphosphonates in the treatment of osteoporosis].
    Papapoulos SE; Lockefeer JH
    Ned Tijdschr Geneeskd; 1991 Mar; 135(13):553-6. PubMed ID: 1902912
    [No Abstract]   [Full Text] [Related]  

  • 55. Recent advances in the prevention and treatment of postmenopausal osteoporosis.
    Shaefer MA
    Ohio Nurses Rev; 1999 Jan; 74(1):3, 5, 10-1 passim; quiz 15. PubMed ID: 10614426
    [No Abstract]   [Full Text] [Related]  

  • 56. Bisphosphonate therapy for osteoporosis.
    Attie MF
    Hosp Pract (Off Ed); 1991 Mar; 26(3A):87-90. PubMed ID: 1900862
    [No Abstract]   [Full Text] [Related]  

  • 57. [Osteoporosis. Fracture as alarm signal].
    MMW Fortschr Med; 2001 Oct; 143(41):56. PubMed ID: 11721665
    [No Abstract]   [Full Text] [Related]  

  • 58. Hormone replacement therapy (HRT) or etidronate for osteoporosis in postmenopausal asthmatics on glucocorticoids: a randomised factorial trial.
    Campbell IA; Douglas JG; Francis RM; Prescott RJ; Reid DM;
    Scott Med J; 2009 Feb; 54(1):21-5. PubMed ID: 19291931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Therapy of osteoporosis with bisphosphonate. Bone quality maintained over years].
    MMW Fortschr Med; 2003 Jun; 145(23):59. PubMed ID: 12854232
    [No Abstract]   [Full Text] [Related]  

  • 60. Further hearing loss during osteoporosis treatment with etidronate.
    Yaşil S; Cömlekçi A; Güneri A
    Postgrad Med J; 1998 Jun; 74(872):363-4. PubMed ID: 9799894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.